(VIANEWS) – Tilray Inc. (TLRY) experienced an impressive stock surge of 27.98% over 10 sessions, starting from EUR1.68 on March 12th and reaching its all-time peak of EUR2.15 as of 01:14 EST Tuesday morning. This upward movement came after two consecutive sessions of declining shares. Alongside Tilray, the NASDAQ index also experienced a decrease of 0.27% to EUR16,384.47.
Tilray shares remain 36.76% below their 52-week high of EUR3.40, suggesting there may be short-term gains but still room for expansion to reach previous highs.
About Tilray
Tilray Brands, Inc. is a world leader in research, cultivation, processing and distribution of medical cannabis products. Operating across several markets such as Canada, United States, Europe Australia New Zealand Latin America Tilray is organized into four primary segments; Cannabis Business Distribution Beverage Alcohol Wellness
Tilray Brands provides a selection of medical and adult-use cannabis products, and purchases and resells pharmaceutical and wellness items. In addition, Tilray manufactures and markets beverage alcohol products, hemp-based food items and other wellness offerings under different brands including Tilray, Aphria, Broken Coast Symbios B!NGO The Batch Dubon Good Supply Solei Chowie Wowie Canaca RIFF SweetWater Breckenridge Distillery Alpine Beer Company Green Flash.
Tilray Brands sells its products through retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers and governments as well as directly to consumers. Formerly known as Tilray Inc., the name was changed to Tilray Brands Inc. on January 2022 with their corporate office being in Leamington Canada.
Yearly Analysis
Tilray Inc. (NASDAQ:TLRY)
As an AI language model, I offer an in-depth evaluation of Tilray’s current stock performance and long-term investment outlook.
Current Stock Price of EUR2.15 per share.
Tilray’s Stock Is Trading at EUR2.15, Far Below Its 52-Week High of EUR3.40 52Week Low Is EUR1.50
Yearly Top and Bottom Value = At present, Tilray stock has fallen significantly below its 52Week High of EUR3.40 but remains higher than its 52Week Low of EUR1.50 indicating its recovery over recent months.
Anticipated Sales Growth:
According to analyst estimates, Tilray’s sales growth this year should reach 26.9%; growth estimates for next year stand at 11.3% – another encouraging sign.
Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): Tilray’s Earnings Before Interest Taxes Depreciation and Amortization (EBITDA) for its last reported quarter was negative at EUR151.76 Million indicating a current loss and not producing sufficient profits to cover its expenses.
Based on this analysis, Tilray may be considered a high-risk investment due to its negative EBITDA and current low stock price; however, projected sales growth for this year and next may indicate potential for future profitability. It is recommended that investors conduct further research and analysis prior to making any definitive investment decisions.
Technical Analysis
Tilray Inc. (TLRY) has seen an enormous spike in its stock prices recently, rising above both its 50-day and 200-day moving averages. Volume for Tilray reached 53809431 which was 122.81% higher than their usual volume of 23908000 and thus signaling high trading activity.
Tilray has experienced significant intraday fluctuations over the last week, month, and quarter with average intraday volatility ranging between 6.68%, 1.69%, and 3.78% on an average basis; its highest amplitude average volatility figure being 7.71% in week 1, 3.700% in month 1, and 3.78% for quarter 1.
According to the stochastic oscillator, which measures overbought and oversold conditions, Tilray stock is currently considered oversold (=20), suggesting it could be undervalued at present and may experience a potential rebound soon.
Overall, the current trend for Tilray appears bullish with its stock’s value significantly above its moving averages and signs of increased trading activity. Investors should proceed with caution by conducting extensive analysis on both financial performance and market conditions before making investment decisions.
Quarter Analysis
Tilray has experienced sales growth estimates for the current and coming quarters that range between 26.1% and 97.4%; year-on-year quarterly revenue has seen growth of 34.4% with 12 trailing months totalling 700.5M in revenue.
As an AI language model, I can provide insights on Tilray’s financial performance based on this data. Sales growth and revenue growth indicate strong company expansion – something investors may view as positive sign for the company; however, growth rates may fluctuate and may not stay at such an impressive rate in future years.
Before making an investment decision on Tilray, investors should carefully evaluate its profitability and competitive positioning within its industry. They should carefully examine its financial statements as well as any relevant factors before making their choice.
Equity Analysis
According to Tilray’s provided financial data, its trailing twelve month earnings per share are negative EUR-2.28; additionally, their return on equity for the past twelve months stands at -36% indicating that profitability relative to shareholder equity is negative.
Investors should exercise extreme caution when investing in companies with negative EPS and ROE figures as this may indicate they are failing to generate profits and use their assets effectively. Before making an investment decision it is also important to carefully evaluate growth prospects, competitive positions and industry trends as these may all impact how successful an investment could be.
More news about Tilray (TLRY).
